Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
30,992,622
-
Shares change
-
+342,716
-
Total reported value, excl. options
-
$749,720,524
-
Value change
-
-$49,296,665
-
Put/Call ratio
-
117%
-
Number of buys
-
72
-
Number of sells
-
-48
-
Price
-
$24.20
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2015
135 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q2 2015.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,992,622 shares
of 386,127,219 outstanding shares and own 8% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4,069,132 shares), JPMORGAN CHASE & CO (2,935,797 shares), JENNISON ASSOCIATES LLC (2,841,248 shares), FRANKLIN RESOURCES INC (2,652,456 shares), WASATCH ADVISORS INC (2,506,418 shares), ORBIMED ADVISORS LLC (2,449,900 shares), FMR LLC (1,093,145 shares), VANGUARD GROUP INC (976,930 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (936,000 shares), and BlackRock Fund Advisors (874,184 shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.